Kevin O’Leary is a world famous venture capitalist who stars on the TV show Shark Tank. Mr. O’Leary is known for giving out tough advice to hopeful entrepreneurs, but with good intentions. O’Leary’s non-traditional approach to business also applies to the companies he invests in outside of reality TV.

Kevin recently made headlines when he backed MindMed; a pharmaceutical organization researching psychedelic-inspired medicines. MindMed is currently trades as MMED on the Canadian NEO Exchange, MMEDF on the American OTC Exchange, and BGHM on the German Frankfurt Exchange.

O’Leary invests in psychedelic companies because he sees the value it has in addressing issues such opioid addiction, alcoholism, Alzheimer’s disease and depression. These problems haven’t had much progress for treatment and medication in decades and he sees psychedelics as a solution.

Mr. O’Leary points out that the MindMed pharmaceutical approach is much different than the route the cannabis industry took. O’Leary believes the collaboration with the FDA on psychedelic medications will result in large returns for early investors.